Developer docs
API playgroundTry for free, no card

Search company profiles

FaceHeart

Full company profile

uuid0007939

Namestring
FaceHeart
Legal namestring
FaceHeart Corporation
Websiteurl
faceheart.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

FaceHeart Corporation is a Taiwan-based AI biosensing company founded in 2018 and headquartered in Taipei. It develops FaceHeart Vitals™, an FDA-cleared video-based software platform that measures vital signs — heart rate, respiration rate, and blood oxygen — by applying AI image recognition to a 50-second facial scan captured through a standard smartphone camera. The company holds two FDA 510(k) clearances (k223622 for Heart Rate and k243966 for Respiration Rate) and is the first video-based vital sign solution to achieve Class II Software as a Medical Device designation, providing regulatory validation that competitors in this category must replicate.

The company monetizes primarily through SDK licensing of FaceHeart Vitals™ (registered as FH Vitals SDK) to healthcare device manufacturers and health tech platforms for embedding contactless vital sign measurement into third-party products, supplemented by a consumer-facing mobile application (FaceHeart AI HealthScan) and direct enterprise deployments to hospitals such as Bangkok Hospital. It is also extending its measurement set with beta biomarkers including HbA1c, hemoglobin, and cholesterol to address chronic disease management and remote patient monitoring use cases aligned with Medicare RPM and CCM frameworks.

FaceHeart raised $200 million in Series A funding from Taiwania Capital Management Corporation in October 2022 and has received industry recognition including Forbes Asia's 100 To Watch 2025 and the 2025 MedTech Breakthrough Awards. The company operates with 11–50 employees across primary customer segments: healthcare providers and medical institutions, device manufacturers and health tech platforms, and underserved or rural populations requiring hardware-free monitoring access.

Short descriptiontext

FaceHeart Corporation is a Taiwan-based AI biosensing company developing FaceHeart Vitals, an FDA-cleared video-based software that measures vital signs via 50-second facial scans. It serves healthcare providers, device manufacturers, and consumers through SDK licensing and a mobile application.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHsinchu, Taiwan
HQ citystring
Hsinchu
HQ countrystring
Taiwan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contactless vital signs, video-based biosensing, AI medical software, remote patient monitoring, FDA-cleared SaMD
Industry5 codes
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHACAD
Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYCRACAQAF
Pulse Oximeters & Respiratory Monitors (Consumer)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Digital Health Monitoring Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SDK Licensing
TypeLicensing Royalties
Description

FaceHeart licenses its FDA-cleared FaceHeart Vitals SDK to device manufacturers and health tech platforms for integration into their products and services. This appears to be the primary revenue stream, enabling contactless vital signs measurement capabilities in third-party devices.

faceheart.com
2Mobile App (AI HealthScan)
TypeSubscription Recurring
Description

Consumer-facing mobile application that provides vital signs measurement functionality. The app processes data locally on the device and only connects to FaceHeart's license server for license validation during activation, suggesting a freemium or subscription model for consumer access.

faceheart.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1FaceHeart Vitals
Description

AI-driven and video-based vital sign solution that measures key vital signs via a 50-second facial scan. Registered as FH Vitals SDK.

faceheart.com
Core offering1 text field

FaceHeart develops and licenses AI-driven video-based vital sign measurement software. Its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) measures heart rate and respiration rate via a 50-second facial scan using standard smartphone cameras, enabling contactless monitoring without specialized medical hardware. The company also offers a consumer-facing FaceHeart AI HealthScan mobile app for personal vital sign measurement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50-second facial scan provides vital sign measurements
+3 more records
Product overview1 text field

FaceHeart offers a platform centered on its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) software, which provides contactless video-based vital sign measurement powered by AI. The core offering integrates with a wide variety of devices and services through its SDK. The product portfolio includes the FaceHeart AI HealthScan mobile application for consumer use and is expanding with beta biomarkers (HbA1c, Hemoglobin, Cholesterol). FaceHeart positions its technology as a solution that reduces reliance on specialized medical hardware by enabling vital sign monitoring through standard smartphone cameras.

Product and service2 records
1FaceHeart Vitals™ (FH Vitals SDK)
CategoryContactless Vital Sign Software (SaMD)
Description

FDA-cleared AI-driven video-based vital sign measurement software that measures key vital signs (heart rate, respiration rate) via a 50-second facial scan using standard smartphone cameras. Designed for integration into third-party devices and services by healthcare device manufacturers, health tech platforms, and enterprise healthcare systems.

2FaceHeart AI HealthScan App
CategoryMobile Health Application
Description

Mobile application that provides contactless vital sign measurement on personal devices (cellphone, digital tablet). Most data is stored locally on the device; the app only connects to FaceHeart's license server for license validation when activated, with no internet transmission of personal or health data. Targeted at individual consumers seeking personal health monitoring.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Binah.ai offers video-based contactless vital sign measurement via facial scan, directly competing with FaceHeart Vitals SDK across the same OEM, telehealth, and enterprise healthcare channels.

TypeDirect peer
Description

Nuralogix's Anura platform measures blood pressure, heart rate, and stress from a 30-second selfie video, making it a direct video-based vital signs competitor targeting consumer health apps and OEMs.

TypeDirect peer
Description

Oxehealth provides contactless video-based vital sign monitoring for hospitals and mental health facilities, competing with FaceHeart's enterprise healthcare deployment motion.

TypeDirect peer
Description

Biobeat offers remote patient monitoring via wearable chest patches measuring 13 vital signs including blood pressure and SpO2; a direct competitor in the RPM and chronic care management market where FaceHeart also plays.

TypeDirect peer
Description

EarlySense provides contactless under-mattress vital sign monitoring for hospitals and post-acute care, competing in the contactless patient monitoring category where FaceHeart also operates.

TypeBroad incumbent
Description

Current Health, acquired by Best Buy Health, offers enterprise-grade RPM including continuous vital sign monitoring and chronic care management, competing with FaceHeart for hospital and RPM service contracts.

7VitalConnect
TypeDirect peer
Description

VitalConnect provides wearable biosensor patches for continuous vital sign monitoring in hospital and remote settings, an alternative contactless/wearable approach for the same RPM customer segments.

TypeBroad incumbent
Description

Apple's Health app and Apple Watch integrate heart rate, respiratory, and increasingly contactless health features; it is a broad incumbent whose consumer reach could subsume FaceHeart's prosumer/OEM use cases.

TypeBroad incumbent
Description

Fitbit (Google) provides wearable vital sign monitoring and population health analytics, a broad incumbent in consumer and enterprise health monitoring that overlaps with FaceHeart's SDK distribution model.

TypeDirect peer
Description

Care.ai offers AI-powered ambient patient monitoring with contactless vital sign sensing for hospital smart rooms, directly competing with FaceHeart's smart mirror and hospital deployment use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FaceHeart

Digital Health Monitoring Softwarefaceheart.com

FaceHeart Corporation is a Taiwan-based AI biosensing company developing FaceHeart Vitals, an FDA-cleared video-based software that measures vital signs via 50-second facial scans. It serves healthcare providers, device manufacturers, and consumers through SDK licensing and a mobile application.

What FaceHeart does

FaceHeart Corporation is a Taiwan-based AI biosensing company founded in 2018 and headquartered in Taipei. It develops FaceHeart Vitals™, an FDA-cleared video-based software platform that measures vital signs — heart rate, respiration rate, and blood oxygen — by applying AI image recognition to a 50-second facial scan captured through a standard smartphone camera. The company holds two FDA 510(k) clearances (k223622 for Heart Rate and k243966 for Respiration Rate) and is the first video-based vital sign solution to achieve Class II Software as a Medical Device designation, providing regulatory validation that competitors in this category must replicate.

The company monetizes primarily through SDK licensing of FaceHeart Vitals™ (registered as FH Vitals SDK) to healthcare device manufacturers and health tech platforms for embedding contactless vital sign measurement into third-party products, supplemented by a consumer-facing mobile application (FaceHeart AI HealthScan) and direct enterprise deployments to hospitals such as Bangkok Hospital. It is also extending its measurement set with beta biomarkers including HbA1c, hemoglobin, and cholesterol to address chronic disease management and remote patient monitoring use cases aligned with Medicare RPM and CCM frameworks.

FaceHeart raised $200 million in Series A funding from Taiwania Capital Management Corporation in October 2022 and has received industry recognition including Forbes Asia's 100 To Watch 2025 and the 2025 MedTech Breakthrough Awards. The company operates with 11–50 employees across primary customer segments: healthcare providers and medical institutions, device manufacturers and health tech platforms, and underserved or rural populations requiring hardware-free monitoring access.

FaceHeart firmographics

Firmographics
Name
FaceHeart
Legal name
FaceHeart Corporation
Website
https://faceheart.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
FaceHeart Corporation is a Taiwan-based AI biosensing company developing FaceHeart Vitals, an FDA-cleared video-based software that measures vital signs via 50-second facial scans. It serves healthcare providers, device manufacturers, and consumers through SDK licensing and a mobile application.
Ownership category
akta.pro rank

FaceHeart industry classification

Industry
Product category
Digital Health Monitoring Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHACAD
Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYCRACAQAF
Pulse Oximeters & Respiratory Monitors (Consumer)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Contactless vital signs
  • Video-based biosensing
  • AI medical software
  • Remote patient monitoring
  • FDA-cleared SaMD

Where FaceHeart is headquartered

Location

Headquarters

HQ city
Hsinchu
HQ country
Taiwan
HQ region
Asia

Offices1 record

Markets served

FaceHeart business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SDK Licensing: FaceHeart licenses its FDA-cleared FaceHeart Vitals SDK to device manufacturers and health tech platforms for integration into their products and services. This appears to be the primary revenue stream, enabling contactless vital signs measurement capabilities in third-party devices.
  2. Mobile App (AI HealthScan): Consumer-facing mobile application that provides vital signs measurement functionality. The app processes data locally on the device and only connects to FaceHeart's license server for license validation during activation, suggesting a freemium or subscription model for consumer access.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

FaceHeart product offering

Product offering

Core offering

FaceHeart develops and licenses AI-driven video-based vital sign measurement software. Its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) measures heart rate and respiration rate via a 50-second facial scan using standard smartphone cameras, enabling contactless monitoring without specialized medical hardware. The company also offers a consumer-facing FaceHeart AI HealthScan mobile app for personal vital sign measurement.

Product overview

FaceHeart offers a platform centered on its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) software, which provides contactless video-based vital sign measurement powered by AI. The core offering integrates with a wide variety of devices and services through its SDK. The product portfolio includes the FaceHeart AI HealthScan mobile application for consumer use and is expanding with beta biomarkers (HbA1c, Hemoglobin, Cholesterol). FaceHeart positions its technology as a solution that reduces reliance on specialized medical hardware by enabling vital sign monitoring through standard smartphone cameras.

Differentiator

Problem solved

Functional benefit

Brands

  • FaceHeart Vitals: AI-driven and video-based vital sign solution that measures key vital signs via a 50-second facial scan. Registered as FH Vitals SDK.

Products and services

  • FaceHeart Vitals™ (FH Vitals SDK) FDA-cleared AI-driven video-based vital sign measurement software that measures key vital signs (heart rate, respiration rate) via a 50-second facial scan using standard smartphone cameras. Designed for integration into third-party devices and services by healthcare device manufacturers, health tech platforms, and enterprise healthcare systems.
  • FaceHeart AI HealthScan App Mobile application that provides contactless vital sign measurement on personal devices (cellphone, digital tablet). Most data is stored locally on the device; the app only connects to FaceHeart's license server for license validation when activated, with no internet transmission of personal or health data. Targeted at individual consumers seeking personal health monitoring.

Quantifiable outcome

  • 50-second facial scan provides vital sign measurements
  • +3 more outcomes

Companies that use FaceHeart

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

FaceHeart technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

FaceHeart partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

FaceHeart competitors and assessment

Company assessment

Direct peers

  • Binah.ai: Binah.ai offers video-based contactless vital sign measurement via facial scan, directly competing with FaceHeart Vitals SDK across the same OEM, telehealth, and enterprise healthcare channels.
  • Nuralogix: Nuralogix's Anura platform measures blood pressure, heart rate, and stress from a 30-second selfie video, making it a direct video-based vital signs competitor targeting consumer health apps and OEMs.
  • Oxehealth: Oxehealth provides contactless video-based vital sign monitoring for hospitals and mental health facilities, competing with FaceHeart's enterprise healthcare deployment motion.
  • Biobeat: Biobeat offers remote patient monitoring via wearable chest patches measuring 13 vital signs including blood pressure and SpO2; a direct competitor in the RPM and chronic care management market where FaceHeart also plays.
  • EarlySense: EarlySense provides contactless under-mattress vital sign monitoring for hospitals and post-acute care, competing in the contactless patient monitoring category where FaceHeart also operates.
  • VitalConnect: VitalConnect provides wearable biosensor patches for continuous vital sign monitoring in hospital and remote settings, an alternative contactless/wearable approach for the same RPM customer segments.
  • Care.ai: Care.ai offers AI-powered ambient patient monitoring with contactless vital sign sensing for hospital smart rooms, directly competing with FaceHeart's smart mirror and hospital deployment use cases.

Broad incumbents

  • Current Health (Best Buy Health): Current Health, acquired by Best Buy Health, offers enterprise-grade RPM including continuous vital sign monitoring and chronic care management, competing with FaceHeart for hospital and RPM service contracts.
  • Apple (Health): Apple's Health app and Apple Watch integrate heart rate, respiratory, and increasingly contactless health features; it is a broad incumbent whose consumer reach could subsume FaceHeart's prosumer/OEM use cases.
  • Google Fitbit Health Solutions: Fitbit (Google) provides wearable vital sign monitoring and population health analytics, a broad incumbent in consumer and enterprise health monitoring that overlaps with FaceHeart's SDK distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

FaceHeart social profiles

Digital presence

FaceHeart compliance and trust

Trust signal

Compliance2 records

FaceHeart financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FaceHeart leadership team

Management profile

Number of profiles

Profiles2 records

FaceHeart funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FaceHeart M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FaceHeart

What does FaceHeart do?

FaceHeart develops and licenses AI-driven video-based vital sign measurement software. Its FDA-cleared FaceHeart Vitals™ (FH Vitals SDK) measures heart rate and respiration rate via a 50-second facial scan using standard smartphone cameras, enabling contactless monitoring without specialized medical hardware. The company also offers a consumer-facing FaceHeart AI HealthScan mobile app for personal vital sign measurement.

Is FaceHeart a public or private company?

FaceHeart is a private company. It is classified as venture growth investor backed and is currently operating.

When was FaceHeart founded?

FaceHeart was founded in 2018. It employs 11 to 50 people.

Where is FaceHeart based?

FaceHeart is headquartered in Hsinchu, Taiwan, in the Asia region.

How does FaceHeart make money?

Two revenue lines are on record. SDK Licensing is the primary driver. The others are mobile App (AI HealthScan).

Who are FaceHeart's main competitors?

Direct peers on record are Binah.ai, Nuralogix, Oxehealth, Biobeat, EarlySense, VitalConnect and Care.ai. Broad incumbents are Current Health (Best Buy Health), Apple (Health) and Google Fitbit Health Solutions.

Does FaceHeart have an API?

No public API is recorded for FaceHeart.

What industry is FaceHeart in?

FaceHeart's product category is Digital Health Monitoring Software. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dealroom.coJapan's TISI backs Taiwan's FaceHeart, maker of FDA-cleared camera vitals techTISIDealroom, a Japanese IT services company, invested in FaceHeart, a Taipei-based startup that uses AI to measure vital signs from facial video. The company's technology holds FDA 510(k) clearances, and TISI will help it expand in Japan, starting with CardioMirror installations at its offices.FaceheartThe Use of AI in Healthcare: A Smart Home Health Care PerspectiveThis article provides an educational overview of smart home healthcare, describing how it integrates AI, IoT, and cloud computing to enable continuous, real-time health monitoring outside clinical settings, supporting chronic disease management and aging-in-place. The article details the technology architecture including sensors, AI analytics layers, and remote patient monitoring capabilities, while highlighting FaceHeart as a featured solution provider whose FaceHeart Vitals™ SDK enables contactless vital signs measurement using standard cameras. The piece also addresses data security considerations, regulatory frameworks like GDPR and HIPAA, and projects a 15% reduction in healthcare costs through AI-enabled remote monitoring.FaceheartFaceHeart’s Perspective: Chronic Disease Management with Remote MonitoringFaceHeart published an educational perspective article on chronic disease management in the United States, highlighting the burden of chronic conditions (affecting 6 in 10 adults) and the role of Medicare programs such as Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) in addressing this public health challenge. The article discusses how FaceHeart's video-based physiological signal monitoring technology, which measures heart rate, blood oxygen, and respiratory rate using smartphone cameras, positions the company within the growing remote monitoring landscape. FaceHeart argues that non-invasive, low-barrier monitoring solutions using everyday devices can improve accessibility for underserved and rural populations while supporting healthcare equity goals aligned with CMS policy directions.FaceheartWhat Is Remote Vital Signs Monitoring? Comprehensive Health Monitoring Insights!The article provides a comprehensive overview of remote vital signs monitoring technologies, detailing the integration of wearables, contactless systems like rPPG, and IoT solutions for healthcare management. It highlights specific commercial implementations by FaceHeart Vitals™ through partnerships with Grupo Red Salud in Peru and Emagine Solutions Technology for maternal care applications. The piece emphasizes the clinical benefits of these tools, such as early intervention for chronic diseases and reduced hospital readmissions.HIT ConsultantThe Journey Pregnancy App Integrates AI Vitals Scan for Maternal HealthEmagine Solutions Technology partnered with FaceHeart to integrate AI-based vital signs scanning into The Journey Pregnancy app, allowing users to measure heart rate, blood pressure, and other maternal health metrics via a 50-second selfie. The technology is free for July 2025, and data can be shared with doctors through EPIC integration.BusinessLineMirror, mirror on the wall… Who’s the futuristic of ’em all?CES 2025 showcased a shift in tech focus towards beauty and wellness, highlighting four innovative smart mirror concepts. Key products include the Samsung MICRO LED Beauty Mirror for skin analysis, the FaceHeart Cardio Mirror for cardiac health assessments, the Withings Omnia personal health monitor, and Kosé's Mixed Reality Makeup try-on system.FaceheartFaceHeart Wins “Best Biometric Sensor Solution” Designation in 2025 MedTech Breakthrough Awards ProgramFaceHeart announced on May 8, 2025 that it won the "Best Biometric Sensor Solution" award in the 9th annual MedTech Breakthrough Awards program. Its FDA-cleared, video-based contactless vital sign solution, FaceHeart Vitals, measures heart rate, blood pressure, respiration rate, oxygen saturation and heart rate variability from a standard RGB camera over 50 seconds. The company has collected over 300 million datasets from more than 6,000 testers across 20+ clinical trials.DIGITIMES AsiaFaceHeart seeks FDA clearance for image-based vital sign measurement technology to capitalize on telemedicine opportunitiesFaceHeart submitted a clinical trial application to the FDA in 2022 for its image-based vital sign measurement technology, which uses a smartphone or tablet camera to measure heart rate, blood pressure, blood oxygen, and respiration. The company expects FDA certifications between 2023 and 2025 and plans to seek CE and HSA certifications for global expansion.PR NewswireTaiwanese Startup FaceHeart Video-based Measurement Software Uses AI to Remotely Measure Vitals Stats of PatientsTaiwanese startup FaceHeart is promoting its AI-powered FH Vitals software, which enables remote, contactless measurement of patient vitals such as heart rate and blood pressure through video analysis. The company recently exhibited the technology at VivaTech 2022 in Paris and has secured investments from MediaTek while awaiting FDA/CDE clearance for medical-grade accuracy. FaceHeart targets expansion into the United States, Europe, and Japan markets for applications in telemedicine and corporate wellness.PR NewswireTTA Startups: FaceHeart, iStaging and ible Technology to Win Global Challenge (Coup de Coeur) at VivaTech 2022Taiwanese startups FaceHeart, iStaging, and ible Technology were selected as 'Judge's Favorites' in the Coup de Coeur challenge at VivaTech 2022. The Ministry of Science and Technology (MOST) and Taiwan Tech Arena (TTA) organized a pavilion to showcase 33 local startups, highlighting innovations in health technology, air purification, and augmented reality.